Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey-Reference-Cited by-同舟云学术

Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

Published:2020-07-10 Issue: Volume:11 Page:
ISSN:1664-2392
Container-title:Frontiers in Endocrinology
language:
Short-container-title:Front. Endocrinol.

Author:

Reiners Christoph,Schneider Rita,Platonova Tamara,Fridman Mikhail,Malzahn Uwe,Mäder Uwe,Vrachimis Alexis,Bogdanova Tatiana,Krajewska Jolanta,Elisei Rossella,Vaisman Fernanda,Mihailovic Jasna,Costa Gracinda,Drozd Valentina

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference60 articles.

1. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very-high risk radiation induced differentiated thyroid carcinoma;Reiners;J Clin Endocrinol Metab,2013

2. Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma – A systematic review;Clement;Cancer Treat Rev,2015

3. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer;Brown;J Clin Endocrinol Metab,2008

4. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management;Kumagai;Endocr J,2007

5. A systematic review and meta-analysis of subsequent malignant neoplasm risk after radioactive iodine treatment of thyroid cancer;Yu;Thyroid,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies;Seminars in Nuclear Medicine;2024-07

2. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study;Frontiers in Endocrinology;2023-05-23

3. The clinical and genetic features in patients coexisting primary breast and thyroid cancers;Frontiers in Endocrinology;2023-05-09

4. Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma;Journal of Personalized Medicine;2023-04-29

5. Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment;British Journal of Cancer;2022-10-12